These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27094484)

  • 1. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.
    He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C
    J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.
    Fogli M; Mavilio D; Brunetta E; Varchetta S; Ata K; Roby G; Kovacs C; Follmann D; Pende D; Ward J; Barker E; Marcenaro E; Moretta A; Fauci AS
    PLoS Pathog; 2008 Jul; 4(7):e1000101. PubMed ID: 18617991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
    Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
    J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.
    O'Connell KA; Han Y; Williams TM; Siliciano RF; Blankson JN
    J Virol; 2009 May; 83(10):5028-34. PubMed ID: 19211742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of IL-15 in challenging Acquired Immunodeficiency Syndrome.
    d'Ettorre G; Andreotti M; Ceccarelli G; Galluzzo CM; Mallano A; Massetti AP; Tierno F; Stella S; Amici R; Vella S; Mastroianni CM; Vullo V
    Cytokine; 2012 Jan; 57(1):54-60. PubMed ID: 22055728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.
    Hölzemer A; Thobakgale CF; Jimenez Cruz CA; Garcia-Beltran WF; Carlson JM; van Teijlingen NH; Mann JK; Jaggernath M; Kang SG; Körner C; Chung AW; Schafer JL; Evans DT; Alter G; Walker BD; Goulder PJ; Carrington M; Hartmann P; Pertel T; Zhou R; Ndung'u T; Altfeld M
    PLoS Med; 2015 Nov; 12(11):e1001900; discussion e1001900. PubMed ID: 26575988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection.
    Yang H; Yorke E; Hancock G; Clutton G; Sande N; Angus B; Smyth R; Mak J; Dorrell L
    J Immunol Methods; 2013 May; 391(1-2):174-8. PubMed ID: 23500782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.
    Song R; Lisovsky I; Lebouché B; Routy JP; Bruneau J; Bernard NF
    PLoS Pathog; 2014 Jan; 10(1):e1003867. PubMed ID: 24453969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of TaqMan real-time PCR and p24 Elisa for quantification of in vitro HIV-1 replication.
    Klein SA; Karsten S; Rüster B; Klebba C; Pape M; Ottmann OG; Hoelzer D; Roth WK
    J Virol Methods; 2003 Feb; 107(2):169-75. PubMed ID: 12505631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.
    Fadda L; Körner C; Kumar S; van Teijlingen NH; Piechocka-Trocha A; Carrington M; Altfeld M
    PLoS Pathog; 2012; 8(7):e1002805. PubMed ID: 22807681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects.
    Eyeson J; King D; Boaz MJ; Sefia E; Tomkins S; Waters A; Easterbrook PJ; Vyakarnam A
    AIDS; 2003 Nov; 17(16):2299-311. PubMed ID: 14571181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease.
    Gómez AM; Smaill FM; Rosenthal KL
    Clin Exp Immunol; 1994 Jul; 97(1):68-75. PubMed ID: 7518369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
    Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
    EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and use of HIV-1 infected primary CD4+ T-cells as target cells in natural killer cell cytotoxic assays.
    Davis ZB; Ward JP; Barker E
    J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells.
    Merino AM; Sabbaj S; Easlick J; Goepfert P; Kaslow RA; Tang J
    Clin Exp Immunol; 2013 Dec; 174(3):414-23. PubMed ID: 23952339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.